SLPSimulations Plus, Inc.
15.37USD0.00%Mkt Cap: 307.53M USDP/E: Last update: 2026-05-26

Simulations Plus, Inc. develops drug discovery and development software for modeling and simulation, and prediction of molecular properties utilizing artificial intelligence and machine learning based technology worldwid…

Indicators:|

Key Statistics

Company
Market Cap307.53M USD
Enterprise Value263.98M USD
Revenue (TTM)80.53M USD
Gross Profit46.22M USD
Net Income (TTM)-64.72M USD
Revenue/Share4.000 USD
Last Price15.37 USD
Fiscal Year EndAug 2025
MR QuarterFeb 2026
Employees212
CountryUS
SectorHealthcare
IndustryHealth Information Services
ISIN
Valuation
P/E (Trailing)
P/E (Forward)16.39
PEG9.88
EV/EBITDA18.91
EV/Revenue3.28
P/S3.79
P/B2.28
EPS (TTM)-3.12
EPS (Forward)0.92
52W Range
11.0919% of range34.01
52W High34.01 USD
52W Low11.09 USD
Profitability
Gross Margin58.38%
Oper. Margin23.18%
EBITDA Margin17.34%
Profit Margin-81.74%
ROE-51.86%
ROA-49.05%
Growth
Revenue Growth8.30%
Earnings Growth46.70%
Cash Flow & Leverage
Operating CF18.13M USD
CapEx (TTM)3.72M USD
FCF Margin21.33%
FCF Yield5.59%
Net Debt-41.33M USD
Net Debt/EBITDA-2.96
Balance Sheet
Debt/Equity0.00
Current Ratio5.47
Quick Ratio5.26
Book Value/Sh6.621 USD
Cash/Share2.071 USD
Dividends
Fwd Div Rate
Trail. Div Rate0.0000 USD
Div. Yield
5Y Avg Yield0.52%
Payout Ratio0.00%
Ex-Div DateJul 29, 2024
Pay DateAug 5, 2024
Splits
Last Split2:1
Split DateOct 2, 2007
Analyst Consensus
Rating
Target (Mean)23.67 USD
Target Range16.00 USD31.00 USD
# Analysts3
Ownership
Shares Out.20.21M
Float16.71M
Insiders17.29%
Institutions83.01%
Short Interest
Short Ratio3.3d
Short % Float9.13%
Short % Out.6.47%
Shares Short1.31M
Short (prev mo.)1.20M
Technical
SMA 5013.51 (+13.8%)
SMA 20015.48 (-0.7%)
Beta1.28
S&P 52W Chg28.31%
Avg Vol (30d)369.26K
Avg Vol (10d)302.26K
Technical Indicators
RSI (14)
MACD
MACD Signal
MACD Hist.
BB Upper
BB Middle
BB Lower
BB Width
ATR (14)
Vol Ratio (20d)